Skip to main content
SpringerLink
Log in

Radiofrequency Ablation for Thoracic Neoplasms

  • Chapter
Tumor Ablation

Abstract

Lung cancer statistics in the United States estimate that 171,900 people in 2003 were diagnosed with lung cancer (1). As the leading cause of cancer death among men and women in the United States, the associated death rate for lung cancer is 28%, surpassing mortality rates of colon, prostate, and breast cancer combined (1). This startling fact underscores the importance of improved methods to treat this aggressive form of cancer. Its ominous prognosis is reflected by the overall 5-year survival rates for previously untreated patients with primary non-small-cell lung cancer (NSCLC) after surgical treatment (according to pathologic stage): 63% to 67% in stage IA, 46% to 57% in IB, 52% to 55% in IIA, 33% to 39% in IIB, and 19% to 23% in IIIA (2,3).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Cancer Facts and Figures 2003. Atlanta: Ameri can Cancer Society, 2003.

    Google Scholar 

  2. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710–1717.

    Article  PubMed  CAS  Google Scholar 

  3. Van Rens M, de la Riviere AB, Elbers HRJ, et al. Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest 2000;117:374–379.

    Article  PubMed  Google Scholar 

  4. Rajdev L, Keller SM. Neoadjuvant and adjuvant therapy of non-small cell lung cancer. Surg Oncol 2002;11:243–253.

    Article  PubMed  Google Scholar 

  5. Dupuy DE, Zagoria RJ, Akerley W, Mayo-Smith W, Kavanagh PV, Safran H. Percutaneous radiofrequency ablation of malignancies in the lung. AJR 2000;174:57–59.

    Article  PubMed  CAS  Google Scholar 

  6. Goldberg SN, Dupuy DE. Image-guided radiofrequency tumor ablation: challenges and opportunities—part I. J Vase Intervent Radiol 2001;12:1021–1032.

    Article  Google Scholar 

  7. Dupuy DE, Goldberg SN. Image-guided radiofrequency tumor ablation: challenges and opportunities—part II. J Vasc Intervent Radiol 2001;12:1135–1148.

    Article  CAS  Google Scholar 

  8. Murai N, Koga K, Nagamachi S, et al. Radiotherapy in bone metastases, with special refer ence to its effect on relieving pain. Gan No Rinsho 1989;35:1149–1152.

    PubMed  CAS  Google Scholar 

  9. Highland AM, Mack P, Breen DJ. Radiofrequency thermal ablation of a metastatic lung nodule. Eur Radiol 2002;suppl 4:S166–S170.

    Google Scholar 

  10. Hoegler D. Radiotherapy for palliation symptoms in incurable cancer. Curr Probl Cancer 1997;21:129–183.

    Article  PubMed  CAS  Google Scholar 

  11. Todd TR. The surgical treatment of pulmonary metastases. Chest 1997;112:287S–290S.

    Article  PubMed  CAS  Google Scholar 

  12. Pastorino U, Buyse M, Friedel G, et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg 1997;113:37–49.

    Article  PubMed  CAS  Google Scholar 

  13. Sakamoto T, Tsubota N, Ivanaga K, et al. Pulmonary resection for metastases from colorectal cancer. Chest 2001;119:1069–1072.

    Article  PubMed  CAS  Google Scholar 

  14. Fourquier P, Regnard J, Rea S, et al. Lung metastases of renal cell carcinoma: results of surgical resection. Eur J Cardiothorac Surg 1997;11:17–21.

    Article  PubMed  CAS  Google Scholar 

  15. Dekernion JB, Ramming KP, Smith RB. The natural history of metastatic renal cell carcinoma: a computer analysis. J Urol 1978;120:148–152.

    PubMed  CAS  Google Scholar 

  16. Kandioler D, Kromer E, Tuchler H, et al. Longterm results after repeated surgical removal of pulmonary metastases. Ann Thorac Surg 1998;65:909–912.

    Article  PubMed  CAS  Google Scholar 

  17. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995;60:615–623.

    Article  PubMed  CAS  Google Scholar 

  18. Kvale RA, Simoff M, Prakash UBS. Palliative care. Chest 2003;123:284S–311S.

    Article  PubMed  Google Scholar 

  19. Griffin JP, Nelson JE, Koch KA, et al. End-of-life care in patients with lung cancer. Chest 2003;123:312S–331S.

    Article  PubMed  Google Scholar 

  20. SUPPORT principal investigators. A controlled trial to improve care for seriously ill hospitalized patients. JAMA 1995;274:1591–1598.

    Article  Google Scholar 

  21. Downey RJ, Martini N, Rusch V, et al. Extent of chest wall invasion and survival in patients with lung cancer. Ann Thorac Surg 1999;68:188–193.

    Article  PubMed  CAS  Google Scholar 

  22. Watson PN, Evans RJ. Intractable pain with lung cancer. Pain 1987;29:163–173.

    Article  PubMed  CAS  Google Scholar 

  23. Jacox A, Carr DB, Payne R, et al. Management of cancer pain: clinical practice guideline No. 9. Rockville, MD: Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, Public Health Service, March 1994; AHCPR Publication No. 94-0592.

    Google Scholar 

  24. Langendijk JA, Ten Velde GPM, Aaronson NK, et al. Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys 2000;47:149–155.

    Article  PubMed  CAS  Google Scholar 

  25. Dupuy DE, Mayo-Smith WW, Abbott GF, DiPetrillo T. Clinical applications of radio-frequency tumor ablation in the thorax. Radio-Graphics 2002;22:S259–S269.

    Google Scholar 

  26. Warzelhan J, Stoelben E, Imdahl A, et al. Results in surgery for primary and metastatic chest wall tumors. Eur J Cardiothorac Surg 2001;19:584–588.

    Article  PubMed  CAS  Google Scholar 

  27. Patti J, Neeman Z, Wood B. Radiofrequency ablation for cancer-associated pain. J Pain 2002;3:471.

    Article  PubMed  PubMed Central  Google Scholar 

  28. McCaughan B. Recent advances in managing non-small-cell lung cancer: 2. Med J Aust 1997;166(suppl):S7–S10.

    PubMed  Google Scholar 

  29. Dupuy DE, Safran H, Mayo-Smith WW, Goldberg SN. Radiofrequency ablation of painful osseous metastatic disease: scientific paper presented at RSNA annual meeting Chicago. Radiology 1998;209S:171S–172S.

    Google Scholar 

  30. Kapural L, Mekhail N. Radiofrequency ablation for chronic pain control. Current Pain Headache Rep 2001;5:517–525.

    Article  CAS  Google Scholar 

  31. Elia S, Griffo S, Gentile M, et al. Surgical treatment of lung cancer invading chest wall: a retrospective analysis of 110 patients. Eur J Cardiothorac Surg 2001;20:356–360.

    Article  PubMed  CAS  Google Scholar 

  32. Sawada M, Watanabe S, Tsuda H, et al. An increase in body temperature during radiofrequency ablation of liver tumors. Anesth Analg 2002;94:1416–1420.

    PubMed  Google Scholar 

  33. Landreneau RJ, Sugarbaker DJ, Mack MJ, et al. Wedge resection versus lobectomy for stage 1(T1 N0 M0) non-small cell lung cancer. J Thorac Cardiovasc Surg 1997;113:691–698.

    Article  PubMed  CAS  Google Scholar 

  34. Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primaries in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995;109:120–129.

    Article  PubMed  CAS  Google Scholar 

  35. Mountain CF. A new international staging system for lung cancer. Chest 1986;89:225–233.

    Article  Google Scholar 

  36. Naruke T, Goya T, Tsuchiya R, et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988;96:440–447.

    PubMed  CAS  Google Scholar 

  37. Shimizu J, Watanabe Y, Oda M, et al. Results of surgical treatment of stage I lung cancer. Nippon Geka Gakkai Zasshi 1993;94:505–510.

    PubMed  CAS  Google Scholar 

  38. Williams DE, Pairolero PC, Danis CS, et al. Survival of patients surgically treated for stage I lung cancer. J Thorac Cardiovasc Surg 1981;82:70–76.

    PubMed  CAS  Google Scholar 

  39. Martini N. Surgical treatment of non-small cell lung cancer by stage. Semin Surg Oncol 1990;6:248–254.

    Article  PubMed  CAS  Google Scholar 

  40. Kodama K, Doi O, Higashiymama M, et al. Intentional limited resection for selected patients with T1 N0 non-small cell lung cancer: a single-institution study. J Thorac Cardiovasc Surg 1997;114:347–353.

    Article  PubMed  CAS  Google Scholar 

  41. Okada M, Yoshikawa K, Hatta T, et al. Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller? Ann Thorac Surg 2001;71:956–960.

    Article  PubMed  CAS  Google Scholar 

  42. Wright SE. Adjuvant chemotherapy and radiation therapy for elimination of residual micro scopic non-small cell lung cancer. Int J Oncol 1999;14:347–351.

    PubMed  CAS  Google Scholar 

  43. Okamoto Y, Murakami M, Yoden E, et al. Reirradiation for locally recurrent lung cancer previously treated with radiation therapy. Int J Radiat Oncol Biol Phys 2002;52:390–396.

    Article  PubMed  Google Scholar 

  44. Temple LK, Brennan MR. The role of pulmonary metastasectomy in soft tissue sarcoma. Semin Thorac Cardiovasc Surg 2002;14:35–44.

    Article  PubMed  Google Scholar 

  45. van der Poel HG, Roukema JA, Horenblas S, van Geel AN, Debruyne FM. Metastasectomy in renal cell carcinoma: a multicenter retrospective analysis. Eur Urol 1999;35:197–203.

    Article  PubMed  Google Scholar 

  46. Piltz S, Meimarakis G, Wichmann MW, et al. Long-term results after pulmonary resection of renal cell carcinoma metastases. Ann Thorac Surg 2002;73:1082–1087.

    Article  PubMed  Google Scholar 

  47. Okumura S, Kondo H, Tsuboi M, et al. Pulmonary resection for metastatic colorectal cancer: experience with 159 patients. J Thorac Cardiovasc Surg 1996;112:867–874.

    Article  PubMed  CAS  Google Scholar 

  48. Labow DM, Buell JE, Yoshida A, Rosen S, Posner MC. Isolated pulmonary recurrence after resection of colorectal hepatic metastases—is resection indicated? Cancer J 2002;8:342–347.

    Article  PubMed  Google Scholar 

  49. Hamy A, Baron O, Bennouna J, Roussel JC, Paineau J, Douillard JY. Resection of hepatic and pulmonary metastases in patients with colorectal cancer. Am J Clin Oncol 2001;24:607–609.

    Article  PubMed  CAS  Google Scholar 

  50. Gauden S, Tripcony L. The curative treatment by radiation therapy alone of stage I non-small cell lung cancer in a geriatric population. Lung Cancer 2001;32:71–79.

    Article  PubMed  CAS  Google Scholar 

  51. Glenn DW, Clark W, Morris DL, et al. Percutaneous radiofrequency ablation of colorectal pulmonary metastases. In: RSNA Conference 2001, November 25–30, Chicago (Abstract 391).

    Google Scholar 

  52. de Baere T, Elias D, Dromain C, et al. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR 2001;175:1619–1625.

    Article  Google Scholar 

  53. Steinke K, Habicht JM, Thomsen S, Soler M, Jacob AL. CT-guided radiofrequency ablation of a pulmonary metastasis followed by surgical resection. Cardiovasc Intervent Radiol 2002;25:543–546.

    Article  PubMed  Google Scholar 

  54. Miao Y, Yicheng N, Bosmans H, et al. Radiofrequency ablation for eradication of pulmonary tumor in rabbits. J Surg Res 2001;99:265–271.

    Article  PubMed  CAS  Google Scholar 

  55. Kishi K, Nakamura H, Sudo A, et al. Tumor debulking by radiofrequency ablation in hyper-trophic pulmonary osteoarthropathy associated with pulmonary carcinoma. Lung Cancer 2002;38:317–320.

    Article  PubMed  Google Scholar 

  56. Ohhigashi S, Nishio T, Watanabe F, et al. Experience with radiofrequency ablation in the treatment of pelvic recurrence in rectal cancer: report of two cases. Dis Colon Recum 2001;44:741–745.

    Article  CAS  Google Scholar 

  57. Callstrom MR, Charboneau JW, Goetz MP, et al. Painful metastases involving bone: feasibility of percutaneous CT-and US-guided radio-frequency ablation. Radiology 2002;224:87–97.

    Article  PubMed  Google Scholar 

  58. Anderson BO, Burt ME. Chest wall neoplasms and their management. Ann Thorac Surg 1994;58:1774–1781.

    Article  PubMed  CAS  Google Scholar 

  59. Pearson FG. Lung cancer: the past twenty-five years. Chest 1986;89(4 suppl):200S–205S.

    PubMed  CAS  Google Scholar 

  60. Wada H, Tanaka F, Yanagihara K. Time trends and survival after operations for primary lung cancer from 1976 through 1990. J Thorac Cardiovasc Surg 1996;112:349–355.

    Article  PubMed  CAS  Google Scholar 

  61. Flehinger BJ, Kimmel M, Melamed MR. The effect of surgical treatment on survival from early lung cancer: implications for screening. Chest 1992;101:1013–1018.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Resident in Radiology, University of California, San Francisco, CA, USA

    Sapna K. Jain MD

  2. Department of Radiology, University Hospital, San Francisco, CA, USA

    Sapna K. Jain MD

  3. Rhode Island Hospital, Providence, RI, USA

    Damian E. Dupuy MD (Professor of Diagnostic Imaging, Brown Medical School, Director of Ultrasound and Office of Minimally Invasive Therapy)

Authors
  1. Sapna K. Jain MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Damian E. Dupuy MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA

    Eric vanSonnenberg MD (Chief of Radiology, Interventional Radiologist) (Chief of Radiology, Interventional Radiologist)

  2. Brigham and Women’s Hospital Children’s Hospital, Boston, MA, 02115, USA

    Eric vanSonnenberg MD (Chief of Radiology, Interventional Radiologist) (Chief of Radiology, Interventional Radiologist)

  3. Boston, MA, 02115, USA

    William N. McMullen (Interventional Oncology Consultant) (Interventional Oncology Consultant)

  4. Department of Radiology, Ospedale Civile Busto Arsizio, 21052, Busto Arsizio, Italy

    Luigi Solbiati MD (Chairman) (Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Jain, S.K., Dupuy, D.E. (2005). Radiofrequency Ablation for Thoracic Neoplasms. In: vanSonnenberg, E., McMullen, W.N., Solbiati, L., Livraghi, T., Müeller, P.R., Silverman, S.G. (eds) Tumor Ablation. Springer, New York, NY. https://doi.org/10.1007/0-387-28674-8_29

Download citation

  • DOI: https://doi.org/10.1007/0-387-28674-8_29

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-95539-1

  • Online ISBN: 978-0-387-28674-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation